ARCHIVES

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

This article is from The Cancer Letter archive.

Vol. 31 No. 5 | May 30, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Plans Progress Review In Lymphoma This Year.

March 10, 2000

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

October 25, 1991

Authorization Bill Passes Senate 82-0

June 27, 1980

Also NCI Cancels von Eschenbach’s Farewell Party, Returns Gift Contributions Amid Ethics Questions.

May 19, 2006

Agency Asks GnRH Sponsors To Add Warnings On Labels

October 22, 2010

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

November 22, 2006